Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Screeners that run automatically... and then email you the results! FREE 30 Day Trial

Menu
Stocks | Futures | Watchlist | More
 
No Matching Results
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact Contact Barchart
Market:

Omega Therapeutics Inc (OMGA)

Omega Therapeutics Inc (OMGA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Alerts
Watch
Help
Go To:
KSQ Appoints Mahesh Karande to its Board of Directors Business Wire - Thu Dec 8, 2022

KSQ Therapeutics, a clinical-stage biotechnology company developing therapies to treat cancer and autoimmune diseases using its proprietary, integrated discovery CRISPRomics® platform, today announced...

OMGA : 4.81 (-23.53%)
Wall Street Analysts Think Omega Therapeutics, Inc. (OMGA) Could Surge 136%: Read This Before Placing a Bet Zacks - Mon Nov 28, 2022

The mean of analysts' price targets for Omega Therapeutics, Inc. (OMGA) points to a 135.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement...

OMGA : 4.81 (-23.53%)
Omega Therapeutics to Participate in the Piper Sandler 34th Annual Healthcare Conference PR Newswire - Thu Nov 17, 2022

/PRNewswire/ -- Omega Therapeutics, Inc. (Nasdaq: OMGA) ("Omega"), a clinical-stage biotechnology company pioneering the first systematic approach to use mRNA...

OMGA : 4.81 (-23.53%)
Wall Street Analysts Believe Omega Therapeutics, Inc. (OMGA) Could Rally 229%: Here's is How to Trade Zacks - Fri Nov 11, 2022

The consensus price target hints at a 229.3% upside potential for Omega Therapeutics, Inc. (OMGA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings...

OMGA : 4.81 (-23.53%)
Omega Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights PR Newswire - Tue Nov 8, 2022

/PRNewswire/ -- Omega Therapeutics, Inc. (Nasdaq: OMGA) ("Omega"), a clinical-stage biotechnology company pioneering the first systematic approach to use mRNA...

OMGA : 4.81 (-23.53%)
Omega Therapeutics to Participate in the Jefferies London Healthcare Conference PR Newswire - Thu Nov 3, 2022

/PRNewswire/ -- Omega Therapeutics, Inc. (Nasdaq: OMGA) ("Omega"), a clinical-stage biotechnology company pioneering the first systematic approach to use mRNA...

OMGA : 4.81 (-23.53%)
Omega Therapeutics Announces First Patient Dosed in Landmark MYCHELANGELO™ I Trial of OTX-2002 in Hepatocellular Carcinoma and Other Solid Tumor Types Associated with the MYC Oncogene PR Newswire - Thu Oct 27, 2022

/PRNewswire/ -- Omega Therapeutics, Inc. (NASDAQ: OMGA) ("Omega"), a clinical-stage biotechnology company pioneering the first systematic approach to use mRNA...

OMGA : 4.81 (-23.53%)
Omega Therapeutics Unveils New Epigenomic Controller Development Candidate Targeting MYC-Driven Non-Small Cell Lung Cancer PR Newswire - Wed Oct 12, 2022

/PRNewswire/ -- Omega Therapeutics, Inc. (Nasdaq: OMGA) ("Omega"), a clinical-stage biotechnology company pioneering the first systematic approach to use mRNA...

OMGA : 4.81 (-23.53%)
Cellarity Announces Close of $121 Million Series C Financing Business Wire - Tue Oct 4, 2022

Cellarity , a life sciences company founded by Flagship Pioneering to transform the way medicines are created, announced today the completion of a $121 million Series C financing, bringing its total funding...

DNLI : 30.49 (-4.60%)
EVLO : 0.9700 (-0.32%)
FHTX : 7.40 (-9.20%)
MRNA : 164.34 (-3.93%)
OMGA : 4.81 (-23.53%)
RUBY : 0.2300 (-12.55%)
SANA : 4.48 (-5.88%)
MCRB : 5.34 (-1.84%)
Omega Therapeutics to Participate in Two Upcoming Investor Conferences PR Newswire - Mon Sep 26, 2022

/PRNewswire/ -- Omega Therapeutics, Inc. (Nasdaq: OMGA) ("Omega"), a clinical-stage biotechnology company pioneering the first systematic approach to use mRNA...

OMGA : 4.81 (-23.53%)

Barchart Exclusives

Here’s a Big Reason to Like Simon Property Group Other Than Real Estate Barchart - Wed Feb 8, 12:53PM CST
Retail REIT Simon Property Group reported stronger-than-expected Q4 2022 results on Monday. But, looking ahead, it sees lower cash flow in 2023. Despite the cloudy profit picture, there’s a big reason to like SPG stock beyond real estate. Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot